Cargando…

Addition of Tolvaptan Compared With Increased Dose of Furosemide in Heart Failure Patients With Chronic Kidney Disease Under Furosemide Treatment

Background: Given that residual congestion is a predictor of poor outcome in patients with heart failure (HF), a therapeutic strategy for decongestion is required. Methods and Results: Eighteen HF patients with fluid retention despite oral furosemide >20 mg/day, with chronic kidney disease (CKD;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Toshiki, Minatoguchi, Shingo, Yamada, Yoshihisa, Kanamori, Hiromitsu, Kawasaki, Masanori, Nishigaki, Kazuhiko, Minatoguchi, Shinya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925130/ https://www.ncbi.nlm.nih.gov/pubmed/33693073 http://dx.doi.org/10.1253/circrep.CR-18-0002

Ejemplares similares

Cardiac Rehabilitation With Dynamic Exercise Increases the Number of Muse Cells in the Peripheral Blood of Patients With Heart Disease
por: Minatoguchi, Shingo, et al.
Publicado: (2018)

Post‐MI treatment with G‐CSF and EPO‐liposome with SLX repairs infarcted myocardium through EPCs mobilization and activation of prosurvival signals in rabbits
por: Yamada, Yoshihisa, et al.
Publicado: (2018)

Excessively low salt diet damages the heart through activation of cardiac (pro) renin receptor, renin-angiotensin-aldosterone, and sympatho-adrenal systems in spontaneously hypertensive rats
por: Okamoto, Chihiro, et al.
Publicado: (2017)

Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study
por: Hattori, Arihiro, et al.
Publicado: (2013)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Re-response to tolvaptan after furosemide dose reduction in a patient with refractory ascites
por: Goto, Atsushi, et al.
Publicado: (2014)

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
por: Tanabe, Norikazu, et al.
Publicado: (2017)

Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure
por: Jujo, Kentaro, et al.
Publicado: (2016)

A new paradigm for the treatment of volume overload in heart failure-combined effect of tolvaptan with furosemide
por: Okamoto, Hiroshi
Publicado: (2013)

Tolvaptan vs. furosemide‐based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA‐AHF)
por: Ng, Tien M.H., et al.
Publicado: (2020)

High Salt Intake Damages the Heart through Activation of Cardiac (Pro) Renin Receptors Even at an Early Stage of Hypertension
por: Hayakawa, Yuka, et al.
Publicado: (2015)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
por: Velat, Ivan, et al.
Publicado: (2020)

Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease
por: Nagayama, Izumi, et al.
Publicado: (2019)

Higher plasma prorenin concentration plays a role in the development of coronary artery disease
por: Yoshida, Gakuro, et al.
Publicado: (2015)

Left Ventricular Torsion in Hypertension and Hypertensive Heart Failure　― 3-Dimensional Speckle Tracking Echocardiography Assessment ―
por: Minatoguchi, Shingo, et al.
Publicado: (2019)

Oral Furosemide and Hydrochlorothiazide/Amiloride versus Intravenous Furosemide for the Treatment of Resistant Nephrotic Syndrome
por: Frățilă, Georgiana, et al.
Publicado: (2023)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

‘Door-to-furosemide’ timing: early treatment of heart failure
por: Piazza, Vito
Publicado: (2019)

An NMR crystallography investigation of furosemide
por: Zilka, Miri, et al.
Publicado: (2018)

Furosemide: No effect: case report
Publicado: (2020)

Use of Oral Furosemide in Hemodialysis
por: Siga, Esteban, et al.
Publicado: (2022)

Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
por: Barzegari, Hasan, et al.
Publicado: (2021)

Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction
por: Yamada, Yoshihisa, et al.
Publicado: (2022)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
por: Yokoyama, Chiharu, et al.
Publicado: (2016)

Furosemide is associated with acute kidney injury in critically ill patients
por: Levi, T.M., et al.
Publicado: (2012)

Effect of continuous furosemide infusion on outcome of acute kidney injury
por: Ni, Jie, et al.
Publicado: (2019)

Furosemide Stress Test in Predicting Acute Kidney Injury Outcomes
por: Rajasekaran, Kishore K, et al.
Publicado: (2020)

The furosemide stress test: Perspectives for acute kidney injury diagnosis
por: Hernández, Francisco J. López
Publicado: (2021)

Albumin and furosemide for acute lung injury
por: Khan, Asjad, et al.
Publicado: (2007)

Liquisolid Systems to Improve the Dissolution of Furosemide
por: Akinlade, Babatunde, et al.
Publicado: (2010)

Temporal bone histopathology of furosemide ototoxicity
por: Santos, Felipe, et al.
Publicado: (2017)

Medullary Nephrocalcinosis in a Furosemide Abuser
por: Hirooka, Nobutaka, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Furosemide: Lack of efficacy: case report
Publicado: (2022)

Response to “Use of Oral Furosemide in Hemodialysis”
por: Flythe, Jennifer E., et al.
Publicado: (2022)

Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis
por: Lee, Tao Han, et al.
Publicado: (2021)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Proteomic differences among patients with heart failure taking furosemide or torsemide
por: Cooper, Lauren B., et al.
Publicado: (2022)

Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease
por: Rivero, Jesús, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41hop36v6aed7ndaggso3m718a